3.99
price down icon3.16%   -0.13
after-market Dopo l'orario di chiusura: 3.95 -0.04 -1.00%
loading

Kyverna Therapeutics Inc Borsa (KYTX) Ultime notizie

pulisher
02:13 AM

Kyverna stock plunges 28% amid data update on lead drug - MSN

02:13 AM
pulisher
Nov 20, 2024

H.C. Wainwright cuts Kyverna stock price target by 14%, keeps Neutral stance - Investing.com

Nov 20, 2024
pulisher
Nov 20, 2024

Kyverna stock maintains Neutral rating as analyst revises outlook amid higher costs - Investing.com

Nov 20, 2024
pulisher
Nov 20, 2024

Kyverna Therapeutics (NASDAQ:KYTX) Price Target Cut to $6.00 by Analysts at HC Wainwright - MarketBeat

Nov 20, 2024
pulisher
Nov 18, 2024

Kyverna Therapeutics Announces New Patient Data Highlighting Pot - GuruFocus.com

Nov 18, 2024
pulisher
Nov 18, 2024

What is Leerink Partnrs’ Forecast for KYTX FY2024 Earnings? - Defense World

Nov 18, 2024
pulisher
Nov 17, 2024

institutional investors of Kyverna Therapeutics, Inc. (NASDAQ:KYTX) must be disappointed after last week's 18% drop - Yahoo Finance

Nov 17, 2024
pulisher
Nov 17, 2024

Wells Fargo & Company Lowers Kyverna Therapeutics (NASDAQ:KYTX) Price Target to $24.00 - Defense World

Nov 17, 2024
pulisher
Nov 14, 2024

Kyverna's CAR T-Cell Therapy Shows Promising Results in Lupus Nephritis Treatment | KYTX Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

Creative Planning Acquires Shares of 11,028 Kyverna Therapeutics, Inc. (NASDAQ:KYTX) - Defense World

Nov 14, 2024
pulisher
Nov 13, 2024

Kyverna Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024
pulisher
Nov 13, 2024

Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results - StreetInsider.com

Nov 13, 2024
pulisher
Nov 09, 2024

(KYTX) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Nov 09, 2024
pulisher
Nov 08, 2024

Analysts Set Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Price Target at $28.71 - Defense World

Nov 08, 2024
pulisher
Nov 05, 2024

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat

Nov 05, 2024
pulisher
Oct 30, 2024

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Short Interest Up 9.7% in October - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

(KYTX) Trading Report - Stock Traders Daily

Oct 29, 2024
pulisher
Oct 27, 2024

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Shares Purchased by Novo Holdings A S - MarketBeat

Oct 27, 2024
pulisher
Oct 24, 2024

Kyverna Therapeutics to Participate in Upcoming September Invest - GuruFocus.com

Oct 24, 2024
pulisher
Oct 22, 2024

Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.

Oct 22, 2024
pulisher
Oct 22, 2024

Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+ - GlobeNewswire

Oct 22, 2024
pulisher
Oct 21, 2024

Kyverna Therapeutics Appoints Mert Aktar to its Board of Directors - cnhinews.com

Oct 21, 2024
pulisher
Oct 21, 2024

Kyverna Therapeutics Appoints Mert Aktar to its Board of Directors | KYTX Stock News - StockTitan

Oct 21, 2024
pulisher
Oct 19, 2024

Kyverna Therapeutics (KYTX): Leading Nano Cap with Promising CAR T-Cell Therapy - Insider Monkey

Oct 19, 2024
pulisher
Oct 18, 2024

(KYTX) Technical Data - Stock Traders Daily

Oct 18, 2024
pulisher
Oct 17, 2024

500: Something went wrong - Investing.com

Oct 17, 2024
pulisher
Oct 17, 2024

JPMorgan bullish on Kyverna Therapeutics stock amid CAR-T expansion potential - Investing.com UK

Oct 17, 2024
pulisher
Oct 17, 2024

7 Best Nano Cap Stocks To Invest In - Insider Monkey

Oct 17, 2024
pulisher
Oct 15, 2024

The Kyverna Therapeutics Inc. (KYTX) had a good session last reading, didn’t it? - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

Kyverna Therapeutics Inc. (KYTX) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle

Oct 14, 2024
pulisher
Oct 14, 2024

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Shares Sold by Marshall Wace LLP - MarketBeat

Oct 14, 2024
pulisher
Oct 14, 2024

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Receives $28.71 Consensus Price Target from Analysts - Defense World

Oct 14, 2024
pulisher
Oct 11, 2024

Kyverna, Cabaletta started at buys by UBS on CAR T therapy potential - MSN

Oct 11, 2024
pulisher
Oct 11, 2024

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Receives $28.71 Consensus Target Price from Analysts - MarketBeat

Oct 11, 2024
pulisher
Oct 11, 2024

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Shares Bought by Millennium Management LLC - MarketBeat

Oct 11, 2024
pulisher
Oct 10, 2024

Buy rating assigned to Kyverna Therapeutics stock as analyst notes promising therapy data - Investing.com

Oct 10, 2024
pulisher
Oct 10, 2024

Down rounds don’t aid post-IPO performance - BioCentury

Oct 10, 2024
pulisher
Oct 10, 2024

JPMorgan Chase & Co's Strategic Acquisition in Kyverna Therapeutics Inc - GuruFocus.com

Oct 10, 2024
pulisher
Oct 10, 2024

Kyverna, Cabaletta started at buys by UBS on CAR T therapy potential (NASDAQ:KYTX) - Seeking Alpha

Oct 10, 2024
pulisher
Oct 10, 2024

Buy rating assigned to Kyverna Therapeutics stock as analyst notes promising therapy data By Investing.com - Investing.com South Africa

Oct 10, 2024
pulisher
Oct 10, 2024

Kyverna Therapeutics (NASDAQ:KYTX) Research Coverage Started at UBS Group - MarketBeat

Oct 10, 2024
pulisher
Oct 10, 2024

Kyverna Therapeutics (NASDAQ:KYTX) Lifted to Strong-Buy at RODMAN&RENSHAW - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

Kyverna Therapeutics (NASDAQ:KYTX) Coverage Initiated by Analysts at Rodman & Renshaw - MarketBeat

Oct 09, 2024
pulisher
Oct 01, 2024

Market Update: Kyverna Therapeutics Inc. (KYTX) Sees Negative Movement, Closing at 4.89 - The Dwinnex

Oct 01, 2024
pulisher
Sep 30, 2024

Novo Holdings A S Acquires 1,050,000 Shares of Kyverna Therapeutics, Inc. (NASDAQ:KYTX) - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

Biotech Kyverna Surges 36% in Debut After Boosting IPO Size - MSN

Sep 30, 2024
pulisher
Sep 29, 2024

MBB Public Markets I LLC Acquires New Stake in Kyverna Therapeutics, Inc. (NASDAQ:KYTX) - MarketBeat

Sep 29, 2024
pulisher
Sep 26, 2024

Deerfield Management Company L.P. Series C Acquires 520,663 Shares of Kyverna Therapeutics, Inc. (NASDAQ:KYTX) - MarketBeat

Sep 26, 2024
pulisher
Sep 26, 2024

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Shares Purchased by Deerfield Management Company L.P. Series C - MarketBeat

Sep 26, 2024
pulisher
Sep 25, 2024

Skandinaviska Enskilda Banken AB publ Acquires 9,385 Shares of Kyverna Therapeutics, Inc. (NASDAQ:KYTX) - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Affinity Asset Advisors LLC Buys Shares of 200,000 Kyverna Therapeutics, Inc. (NASDAQ:KYTX) - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Affinity Asset Advisors LLC Takes $1.50 Million Position in Kyverna Therapeutics, Inc. (NASDAQ:KYTX) - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Bank of New York Mellon Corp Purchases Shares of 55,790 Kyverna Therapeutics, Inc. (NASDAQ:KYTX) - Defense World

Sep 25, 2024
pulisher
Sep 24, 2024

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Shares Acquired by Great Point Partners LLC - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Great Point Partners LLC Increases Stock Holdings in Kyverna Therapeutics, Inc. (NASDAQ:KYTX) - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

A Tale of Resilience: Kyverna Therapeutics Inc. Amid Stock Market Turbulence - The InvestChronicle

Sep 24, 2024
pulisher
Sep 24, 2024

XTX Topco Ltd Acquires Shares of 83,286 Kyverna Therapeutics, Inc. (NASDAQ:KYTX) - Defense World

Sep 24, 2024
pulisher
Sep 23, 2024

ECTRIMS 2024: Driving a fast CAR on the MS road and beyond - BioWorld Online

Sep 23, 2024
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Capitalizzazione:     |  Volume (24 ore):